<?xml version="1.0" encoding="UTF-8"?>
<akn:akomaNtoso xmlns:akn="http://docs.oasis-open.org/legaldocml/ns/akn/3.0"><akn:act><akn:meta><akn:identification source="#cosilico"><akn:FRBRWork prescriptive="true" authoritative="true"><akn:FRBRuri value="/akn/us/usc/21/387k" /><akn:FRBRdate date="2025-12-31" name="retrieval" /><akn:FRBRauthor href="#us-congress" /><akn:FRBRcountry value="us" /></akn:FRBRWork><akn:FRBRExpression><akn:FRBRuri value="/akn/us/usc/21/387k/eng@2025" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /><akn:FRBRlanguage language="en" /></akn:FRBRExpression><akn:FRBRManifestation><akn:FRBRuri value="/akn/us/usc/21/387k/eng@2025/main.xml" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /></akn:FRBRManifestation></akn:identification></akn:meta><akn:body><akn:section eId="sec_387k"><akn:num>387k</akn:num><akn:heading>Modified risk tobacco products</akn:heading><akn:content><akn:p>§ 387k. Modified risk tobacco products(a) In generalNo person may introduce or deliver for introduction into interstate commerce any modified risk tobacco product unless an order issued pursuant to subsection (g) is effective with respect to such product.


(b) DefinitionsIn this section:(1) Modified risk tobacco productThe term “modified risk tobacco product” means any tobacco product that is sold or distributed for use to reduce harm or the risk of tobacco-related disease associated with commercially marketed tobacco products.


(2) Sold or distributed(A) In generalWith respect to a tobacco product, the term “sold or distributed for use to reduce harm or the risk of tobacco-related disease associated with commercially marketed tobacco products” means a tobacco product—(i) the label, labeling, or advertising of which represents explicitly or implicitly that—(I) the tobacco product presents a lower risk of tobacco-related disease or is less harmful than one or more other commercially marketed tobacco products;

(II) the tobacco product or its smoke contains a reduced level of a substance or presents a reduced exposure to a substance; or

(III) the tobacco product or its smoke does not contain or is free of a substance;


(ii) the label, labeling, or advertising of which uses the descriptors “light”, “mild”, or “low” or similar descriptors; or

(iii) the tobacco product manufacturer of which has taken any action directed to consumers through the media or otherwise, other than by means of the tobacco product’s label, labeling, or advertising, after June 22, 2009, respecting the product that would be reasonably expected to result in consumers believing that the tobacco product or its smoke may present a lower risk of disease or is less harmful than one or more commercially marketed tobacco products, or presents a reduced exposure to, or does not contain or is free of, a substance or substances.


(B) LimitationNo tobacco product shall be considered to be “sold or distr</akn:p></akn:content><akn:subsection eId="subsec_387k_a"><akn:num>(a)</akn:num><akn:heading>In general</akn:heading><akn:content><akn:p>(a) In general No person may introduce or deliver for introduction into interstate commerce any modified risk tobacco product unless an order issued pursuant to subsection (g) is effective with respect to such product.</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_387k_b"><akn:num>(b)</akn:num><akn:heading>Definitions</akn:heading><akn:content><akn:p>(b) Definitions In this section:</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_387k_c"><akn:num>(c)</akn:num><akn:heading>Tobacco dependence products</akn:heading><akn:content><akn:p>(c) Tobacco dependence products A product that is intended to be used for the treatment of tobacco dependence, including smoking cessation, is not a modified risk tobacco product under this section if it has been approved as a drug or device by the Food and Drug Administration and is subject to the requirements of subchapter V.</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_387k_d"><akn:num>(d)</akn:num><akn:heading>Filing</akn:heading><akn:content><akn:p>(d) Filing Any person may file with the Secretary an application for a modified risk tobacco product. Such application shall include—</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_387k_e"><akn:num>(e)</akn:num><akn:heading>Public availability</akn:heading><akn:content><akn:p>(e) Public availability The Secretary shall make the application described in subsection (d) publicly available (except matters in the application which are trade secrets or otherwise confidential, commercial information) and shall request comments by interested persons on the information contained in the application and on the label, labeling, and advertising accompanying such application.</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_387k_f"><akn:num>(f)</akn:num><akn:heading>Advisory Committee</akn:heading><akn:content><akn:p>(f) Advisory Committee</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_387k_g"><akn:num>(g)</akn:num><akn:heading>Marketing</akn:heading><akn:content><akn:p>(g) Marketing</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_387k_h"><akn:num>(h)</akn:num><akn:heading>Additional conditions for marketing</akn:heading><akn:content><akn:p>(h) Additional conditions for marketing</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_387k_i"><akn:num>(i)</akn:num><akn:heading>Postmarket surveillance and studies</akn:heading><akn:content><akn:p>(i) Postmarket surveillance and studies</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_387k_j"><akn:num>(j)</akn:num><akn:heading>Withdrawal of authorization</akn:heading><akn:content><akn:p>(j) Withdrawal of authorization The Secretary, after an opportunity for an informal hearing, shall withdraw an order under subsection (g) if the Secretary determines that—</akn:p></akn:content></akn:subsection></akn:section></akn:body></akn:act></akn:akomaNtoso>